Abstract Details

Title Low Affinity Ex Vivo Neutralizing Antibodies May Enhance the Therapeutic Effect of IFN[beta] in Multiple Sclerosis

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 023

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Nils Koch-Henriksen, MD (Dept of Neurology, Aalborg Hospital)	Dr. Koch-Henriksen has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��